🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Productive year at the MedUni Wien! Deeply grateful to the amazing one and only Shahrokh F. Shariat for truly exceptional mentorship, and to Pawel Rajwa for years of teaching and support. Go fellows!

🌟📢 ASCO #GU25 | Abstract #308 🔬 PORTOS predicts response to RT dose escalation (DE) in prostate cancer.🌟 Alan Dal Pra, MD 📊 Key Findings from Phase III trials: ✅ Intermediate/high PORTOS: Significant RT DE benefit in Phoenix BF & CPFS. ✅ Low PORTOS: No benefit from RT DE. 🧬

The Global 🍆 Rankings Are In! In our meta-analysis, we examined penis length & circumference in 36,883 men across WHO regions to answer one of the most debated questions... "Who has the biggest one?" The results might shock you! Read the full study here: urologyresearchandpractice.org/en/a-systemati…

Just out in European Urology 👌 @martinmiszcyk ⏩Many patients with mUC selected for MDT achieve long-term survival, particularly those with lung metastases ⏩MDT emerges as a promising research direction, with novel systemic therapies capable of eliciting sustained responses

When academia serves it purpose! Thank you, @ian_tannok, for this brillant appraisal! ascopubs.org/doi/full/10.12…

Our new SR and MA published in European Urology Oncology evaluates focal therapy for localized PCa using prospective data only. Important for patient counselling. 📊 50 studies, 4,615 patients 📊 12-mo csPCa RFS in intermediate-risk: 79% (95% CI 74–83%) 🔗 doi.org/10.1016/j.euo.…

Reflecting on the inspiring observership with Prof. Leapman at Yale earlier this year. Now that our discussed projects are underway, we can appreciate how in-person contact sparks creativity. However, the friendships formed along the way are perhaps most valuable.

Thrilled to be published in European Urology for the second time! PSMA-PET holds PROMISE to transform prostate cancer treatment: doi.org/10.1016/j.euru… Big Kudos to Madeleine Karpinski and Wolfgang Fendler for leading this transformative project!

Great to see many enthusiastic colleagues at our Co-IMPACT meeting. Thanks to all for coming and bringing this huge project forward! #ESTRO2025

📢 STORM trial breaking results at #ESTRO25! 🧪 MDT vs ENRT+MDT for nodal oligorecurrent PCa. 🧬 ENRT+MDT: ✅ Superior bRFS (57% vs 41%, p=0.014) ✅ Superior pelvic control (lrRFS 85% vs 62%, p=0.006) ✅ Superior MFS (76% vs 63%, p=0.06) ❌ No increase in ≥G2 GU/GI toxicity

IEO European Institute of Oncology - Giuseppe Curigliano and Barbara Jereczek-Fossa have been elected to lead ESMO and ESTRO ESMO - Eur. Oncology ESTRO IEO G Curigliano MD PhD prof. Barbara Jereczek-Fossa oncodaily.com/blog/giuseppe-… #Cancer #Medicine #Health #ESMO #ESTRO #MedX #MedNews #MedX

Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with #ProstateCancer Treated with Androgen Receptor Pathway Inhibitors eu-focus.europeanurology.com/article/S2405-… This meta-analysis of 14 studies including 8,883 patients evaluated the association between

Very proud to have received top prostate cancer abstract award at the 51. Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung! The past year under the mentorship of Shahrokh F. Shariat and with the support of European Association of Urology (EAU) has been